RhyGaze

About RhyGaze

RhyGaze is dedicated to restoring vision for patients with vision loss caused by retinal cell dysfunction through innovative gene therapy. Their mission is to turn the possibility of vision restoration into reality using advanced genetic technologies.

Products & Services

Gene Therapy for Vision Restoration:A platform combining optogenetic proteins and gene therapy tools to engineer photosensitivity into target cells in the human eye, aimed at restoring sight for individuals with vision loss.

Specialties

Gene Therapy Optogenetics Ophthalmology Vision Restoration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 86000000 MR: - FA: USD 86 million FAN: 86000000	D: 2025-01-10 FD: 2025-01-10	5 investors

Series A Latest

2025-01-10

$86.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Bence György

IOB Assistant Professor & Head of Clinical Translation

B

Botond Roska

IOB Co-Director

C

Charles Gubser

IOB Co-Director

D

Dan Takefman

Chief Development Officer

H

Heather Floyd

Chief Operating Officer

P

Paulo Falabella

Chief Medical Officer

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

RhyGaze Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised